Correlation between Risk Stratification  of Complications and Types of Antihyperglycemia Drugs with Incidence of Acute Diabetic Complications in Patients with Diabetes Mellitus during Ramadan Fasting by Sasiarini, Laksmi et al.
  
 




diterima pada 29 Mei, 2020; 
direvisi pada 18 Juli, 2020; 
disetujui pada 2 September, 
2020 
  
    Original Article 
Hubungan antara Stratifikasi Risiko Komplikasi dan Jenis Obat 
Antihiperglikemia terhadap Kejadian Komplikasi Akut pada Pasien Diabetes 
Mellitus yang Menjalankan Ibadah Puasa Ramadan 
Charisma Dian Simatupang1, Laksmi Sasiarini2, Putu Moda Arsana2  
1 Program Studi Pendidikan Dokter Spesialis I, Departemen  llmu Penyakit Dalam, Fakultas Kedokteran, Universitas Brawijaya – RSUD dr. 
Saiful Anwar, Malang 
2 Divisi Endokrinologi, Metabolik, dan Diabetes, Departemen Ilmu Penyakit Dalam –  dr. Saiful Anwar, General Hospital, Malang 
 
T E N T A N G   A R T I K E L 
 
Penanggungjawab: Laksmi 
Sasiarini, Divisi Endokrinologi, 
Metabolik, dan Diabetes, 
Departement Ilmu Penyakit Dalam, 
Fakultas Kedokteran, Universitas 
Brawijaya, - RSUD dr. Saiful Anwar 
Email: keenarku@yahoo.com 
 
A B S T R A K  
Pasien Diabetes Melitus (DM) yang menjalankan puasa Ramadan, dapat mengalami 
komplikasi akut hipoglikemia, hiperglikemia, ketoasidosis diabetik (KAD) dan trombosis. 
Selama puasa Ramadan terjadi perubahan dosis dan waktu konsumsi obat 
antihiperglikemia. Stratifikasi risiko komplikasi memprediksi keamanan berpuasa pasien 
DM. Tujuan: Mengetahui hubungan stratifikasi risiko puasa Ramadan dan jenis obat 
antihiperglikemia terhadap kejadian komplikasi akut pada pasien DM yang menjalankan 
puasa Ramadan.Metode: Penelitian survei dengan pengambilan data pre dan post. Pasien DM 
pada Poliklinik Endokrinologi RSU Dr. Saiful Anwar Malang yang menjalankan puasa 
Ramadan digolongkan dalam stratifikasi risiko IDF-DAR 2016. Subyek melakukan 
pemantauan glukosa darah mandiri dan mengisi buku kendali harian selama puasa. Hasil: 
Total 37 subyek, 1 pasien DM tipe 1 dan 36 pasien DM tipe 2, memiliki rerata lama puasa 18 
hari. Komplikasi akut terbanyak ditemukan pada kelompok risiko sangat tinggi (5/6) 
dibandingkan kelompok risiko ringan/sedang (2/13) maupun kelompok risiko tinggi 
(7/18) (p=0.009). Komplikasi akut terbanyak ditemukan pada terapi kombinasi OAD dan 
insulin (2/4) dibandingkan pada subyek dengan terapi OAD (9/24) atau insulin (3/9) 
namun tidak berbeda secara signifikan (p=0.731). Tidak ada subyek yang mengalami KAD. 
Trombosis berupa sindroma koroner akut terjadi pada 1 subyek dengan risiko sangat tinggi. 
Terdapat hubungan signifikan antara stratifikasi risiko dengan insidens hipoglikemia 
(p=0.040) dan hiperglikemia (p=0.031). Risiko relatif komplikasi akut pada kelompok 
risiko sangat tinggi dibanding dengan risiko ringan/sedang adalah 2.538 (p=0.046), RR 
(95% CI)= 0.77 (0.62-0.96). Kesimpulan: Terdapat hubungan antara stratifikasi risiko 
dengan komplikasi akut pada pasien DM yang menjalankan puasa Ramadan. Tidak terdapat 
hubungan antara jenis obat antihiperglikemia dengan komplikasi akut puasa Ramadan. 
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A B S T R A C T  
Ramadan fasting for Diabetes Mellitus (DM) patients can lead to acute complications such as 
hypoglycemia, hyperglycemia, diabetic ketoacidosis (DKA) and thrombosis. Risk 
stratification predicts fasting safety of DM patients. Dose and timing of antihyperglycemia 
drugs adjusted during Ramadan fasting. Aim: To know the correlation between the risk 
stratification of Ramadan fasting and type of antihyperglycemia drugs with the incidence of 
acute complications in DM patients undergoing Ramadan fasting. Methods: DM patients in 
Endocrinology Clinic, dr. Saiful Anwar, General Hospital Malang who intend to fast during 
Ramadan classified in IDF-DAR risk stratification, conduct blood glucose monitoring and 
filled out a daily logbook during fasting. Results: Thirty-seven subjects were included in the 
study, only 1 patient with type-1 DM. Average fasting time is 18 days. Acute complications 
found higher in very high-risk group (5/6) compared to mild/moderate (2/13) and high-
risk group (7/18) (p=0.009). Acute complications found higher in group with OAD and 
insulin combination regiment (2/4) compared to OAD (9/24) or insulin group (3/9) (p= 0. 
731). One subject in very high-risk group suffered from acute coronary syndrome. 
Relationship between risk stratification and the incidence of hypoglycemia (p=0.040) and 
hyperglycemia (p=0.031) was significant. Relative risk in the very high-risk group was 2.538 
compared to mild/moderate risk RR (95% CI)= 0.77 (0.62-0.96). Conclusions: There is a 
correlations between risk stratification and acute complications in DM patients undergoing 
Ramadan fasting. No relationship between type of antihyperglycemia drugs with acute 
complications of Ramadan fasting. 
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I N T R O D U C T I O N  
Doing Ramadan fasting is one of the 
five pillars in Islam which obliges Muslims to 
refrain between dawn and dusk from food, 
drink, and all forms of immoral behavior that 
can make the fasting is not valid.  
Epidemiology of Diabetes and Ramadan 
(EPIDIAR) study in 2001 which investigated 
about the diabetic patient in 13 Islamic states 
resulted 42.8% type-1 DM patient and 78.7% 
type-2 DM patient who fast during Ramadan.[1] 
Indonesia is one of country with the largest 
Muslims population in the world.  In 2015, 
there are 10 million of DM patients in 
Indonesia and 87.2% among them are 
Muslims (WHO-Diabetes country profile, 
2015). [2] 
During fasting, there are some changes 
which are diet, sleep pattern, physical 
activities, dosage, also the timing   
antihyperglycemic drugs consumption.[3] It is 
potentially causing an uncontrollable blood 
glucose in diabetes patients who fast during 
Ramadan. The diabetes patient who fasts can 
lead to acute complication such as 
hypoglycemic, hyperglycemic (with or 
without ketoacidosis), dehydration and 
thrombosis (IDF-DAR, 2016). [2] 
The Result of EPIDIAR study showed 
Ramadan fasting can increase severe 
hypoglycemia (SH) risk which needs medical 
treatment at hospital. Hypoglycemia had 
increased 4.7 times to type-1 DM patient and 
7.5 times as frequent to type-2 DM patient. 
Those numbers were not included in home 
treatment.[2] The use of oral antihyperglycemic 
drug which have function to increase insulin 
secretion to the pancreas can lead to the 
hypoglycemia incident. 
During fasting, blood glucose level will 
be decreased, thus it causes secretion 
degradation by the insulin and improvement 
of contra-insulin hormone, which are glycogen 
and glucose. It will cause fatty acid release 
from the adipocyte and producing ketone 
which will be used as an energy by the 
organs.[4] In normal body, insulin and contra-
insulin hormones will be at the balance-
condition. However, in diabetes patient, the 
balance will be disturbed. Fasting can cause 
breakdown of excessive glycogen and 
increased gluconeogenesis also ketogenesis 
that cause hyperglycemia and ketoacidosis.[5] 
Study of EPIDIAR showed the 
incidence of higher risk of hyperglycemia in 
Ramadan that needs hospitalization was 
increased by 5 times in type-2 DM patients, 
while the incidence of higher risk of 
hyperglycemia (with or without ketoacidosis) 
in type-1 DM patients was increased by 3 
times. Hyperglycemia can be caused by 
increasing food consumption and excessive 
glucose also excessive doses decreased that 
had done to prevent hypoglycemia.[6] 
A limited fluid intake during fasting, 
especially in a long term can cause 
dehydration. It makes the patient heavy in hot 
weather and high-humidity areas. Also, it 
might be happened frequently to individual 
who performs strenuous activities.[7] Besides, 
hyperglycemia can cause osmotic diuresis 
which can provoke volume depletion and 
electrolyte. Patient with autonomic 
neuropathy may develop orthostatic 
hypotension which cause syncope.[8] 
Intravascular volume reduction as a result of 
hypovolemia will increase thrombosis 
tendency, especially in patient who tend to 
have hypercoagulable state. The blood 
viscosity increase due to dehydration will 
increase stroke risk and thrombosis.[9] 
However, one investigation showed the 
incident of hospitalization due to coronary 
diseases or stroke did not increase during 
Ramadan.[10] 
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Fasting during Ramadan might be can 
cause serious health issues for diabetes 
patient. But there were a lot of diabetes patient 
who still want to do Ramadan fasting even 
though it can be harmful for themselves 
medically. Doctor plays a role to give insight 
and guidance about the impact of fasting to the 
patient’s medical condition.[11] The last 
decision whether the patient is willing to fast 
or not is on themselves. If they insist to fast, 
then they must get the guidance and 
suggestion about the meal plan, physical 
activities, periodic blood glucose monitoring, 
and timing of antihyperglycemic drug 
consumption which be applied to patient 
during fasting.[12] 
To help giving a guidance about the 
safety of Ramadan fasting for diabetes patient, 
International Diabetes Federation 
collaborated with The Diabetes and Ramadan 
International Alliance (IDF-DAR) make a risk 
stratification which classify diabetes patients 
into some groups. Those were mild-moderate 
risk group, high-risk, and very high-risk to 
experience an acute complication during 
Ramadan fasting.[11] These stratifications were 
applied in pre-fasting screening as an advice 
for the diabetes patient considering to their 
safety during fasting.  
All this time, the use of risk 
stratification is for knowing the DM patient’s 
characteristics based on complication risk that 
may be happened.[12] Majority of Muslims are 
insisting to fast despite there is an exception in 
Islam for the one who suffers from serious 
health problems like Diabetes Mellitus. It leads 
DM patient who is fasting have various risk 
stratification, which means they have different 
susceptibility to acute complications.[13] 
This study aims to find out a 
correlation between risk stratification for 
complications and correlation between types 
of antihyperglycemic drug to the incidence of 
acute complication in DM patient who fasts in 
Ramadan. 
M E T H O D S 
  It used a survey method by taking the 
pre and post data. Subject of the research is 
DM patients who fast in Ramadan, especially 
those who visit the Endocrine-Metabolic 
Outpatient Installation regularly in dr. Saiful 
Anwar General Hospital, Malang. Only those 
who meets the inclusion criteria and not listed 
in exclusion criteria that became the subject of 
the research. 
  We conducted the research during 
Ramadan 1438 H, which was May 25, 2017 
until June 25, 2017. We conducted the 
screening of risk categorization and 
counseling since 4 until 6 weeks ago before 
Ramadan.  
  We gave the patient an Accu-chek 
Performa II Glucose Meter Kit which has been 
calibrated first, daily note during Ramadan 
fasting, alcohol swab, and lancet. Subjects and 
the associate will get education about the way 
of Self-Monitoring of Blood Glucose (SMBG) 
with the way demonstrating it in front of the 
subject. To assure the understanding of the 
subject about the kit, we asked the subjects to 
demonstrate it in front of the researchers 
based on what we explained before.  
  We explained the way of filling out the 
daily note that must be filled during Ramadan 
fasting. It covered description about patients’ 
food consumption, their physical activities, the 
timing and doses of antihyperglycemic drug 
during fast in Ramadan based on the 
researcher’s recommendation, blood glucose 
rate with SMBG, also the complaints during 
fasting in Ramadan. We explained regarding to 
the signs and symptoms of hypoglycemia, 
hyperglycemia, dehydration, and thrombosis. 
We also told them to do SBGM as soon as they 
felt the signs of acute complication. 
  During first week of Ramadan fasting, 
patients measured blood glucose rate 1 
once/every day between 9.00 a.m. till 10.00 
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a.m. and when they felt the acute complication 
signs. In the second and third week of 
Ramadan, patient should check their blood 
glucose before iftar and 2 hours before having 
heavy meal or having iftar every twice a day 
and when the problem arose that lead to acute 
complication. We told them to contact the 
researchers if they experienced the problems. 
The research team contact the subject by 
phone minimum once a week. Patients had to 
record in daily note regarding to the day when 
they did not fast or the time when they ruined 
their fast. We asked them to go back to 
Endocrinology Clinic, dr. Saiful Anwar, General 
Hospital, Malang in 3-5 days before Eid Al-Fitr 
to return the kit and daily note, also taking 
data of post-fasting; weight, blood pressure, 
and discussed about their process during 
Ramadan fasting. 
  We analyzed the data using univariate 
and bivariate analysis. In univariate, we 
served the data in the form of frequency 
distribution for categorical data and served in 
the form of average (mean ± SD) for 
continuous data. In bivariate, on the 
correlation examination between risk 
stratification and types of drug toward acute 
complication was done by Chi-Square analysis. 
If the Chi-Square requirements cannot be 
fulfilled, then we used Kruskal Wallis. We used 
Mann Whitney to examine the correlation 
between the first categorical data and the 
other categorical data. An Analysis Pearson 
correlation was used in normal data 
distribution and Spearman correlation 
analysis was used in abnormal data 
distribution. 
  We computerized analysis a whole 
technique of statistical analysis using 
Statistical Product and Service Solution (SPSS) 
software, IBM SPSS Statistics 20 with the 
significant level or probability value 0.05 
(p=0.05) and confidence level 95% (α = 0.05). 
R E S U L T 
  There were 37 subjects of the 











Figure 1. Demography and Description of the 
Clinical Subject  
 
Characteristics of Subject 
 Characteristics of research subject are 
listed on Table 1. Subject was categorized into 
3 risk stratification groups based on IDF-DAR 
2016 which were mild-moderate risk group, 
high-risk group, and very high-risk group with 
the characteristic description. It was explained 



















Table 1. Characteristics of Research Subject 
Characteristics Mean/ Proportion 
Total (n) 





18 (48.35 %) 
19 (51.35%) 
age (years) 60.08±11.34 
 DM Types 
   Type-1 DM 




58 samples of DM patient who met 
inclusion criteria 
Drop out: 
- the SMBG kit malfunction (2) 
- the SMBG was not conducted (2) 
- incomplete data (6) 
Exclusion: 
- HbA1c >10.3% (1) 
n = 37 the samples will be analyzed 
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Duration of DM (years) 
   < 10 years 
   ≥ 10 years 
7.14  5.27 
25 (67.57%) 
12 (32.43%) 
Weight(kg) 62.94 9.86 
Medical History 
 OAD  
SU (Sulfonylurea) 
Biguanide + SU 
SU + Acarbose 
Biguanide + SU + Acarbose 
Insulin 









HbA1c of pre-Ramadan (%) 8.03  2.03 
FBG (Fasting Blood Glucose) 
(mg/dl) 
GD2PP (2-hours post-prandial) 
(mg/dl) 
134.32  50.11 
181.59  51.48 
Lipid Profiles in pre-Ramadan 
Total of Cholesterol (mg/dl) 
HDL (High Density Lipoprotein) 
(mg/dl) 




185.91  37.64 
50.31  24.00 
118.06  34.15 
170.85  93.30 










7 (18.4 %) 
8 (21 %) 
 
1 (2.6 %) 
0 (0%) 
3 (7.9 %) 
Average Lengths of Fasting (day) 18 days 
*DM, Diabetes Mellitus;OAD, Oral Antidiabetic; HbA1c, 
Haemoglobin A1c; FBG, Fasting Blood Glucose; GD2PP, 2-hours 




























   Type-1 DM 
























































*DM, Diabetes Mellitus;OAD, Oral Antidiabetic; HbA1c, 
Haemoglobin A1c; FBG, Fasting Blood Glucose; GD2PP, 2-hours 
post-prandial 
Acute Complications 
  Acute complications which happened 
during Ramadan fasting are known through 
daily record that contains blood glucose 
through SMBG based on scheduled monitoring 
in the first, second, third, and when patients 
get complaint or clinic symptoms that lead to 
acute complication, also patient’s live report to 
the research team. 












Very high     
Hypoglycemia 5 4 0 1 
Hyperglycemia 12 6 2 4 
Thrombosis 1 0 0 1 
DKA 0 0 0 0 
High     
Hypoglycemia 17 7 3 7 
Hyperglycemia 19 10 6 3 
Thrombosis 0 0 0 0 
DKA 0 0 0 0 
Moderate     
Hypoglycemia 1 0 1 0 
Hyperglycemia 2 2 0 0 
Thrombosis 0 0 0 0 
DKA 0 0 0 0 
*DKA, Diabetic Ketoacidosis 
 
Results of Blood Glucose Monitoring based on 
Complaints and Clinical Symptoms 
 In the first week, hypoglycemia 
occurred 11 times, which were 7 times on 1 
subject in high-risk group, and in 2 subjects of 
very high-risk group who has hypoglycemia 
occurred once and 3 times. It occurred 
between 12.00 p.m. till before iftar. The lowest 
recorded blood glucose level was 53 mg/dL. 
 In the second week, hypoglycemia 
occurred 3 times out of the monitoring 
schedule. It occurred at 14.00-15.00 WIB, 
which were once in one subject of 
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mild/moderate risk group, twice in one 
subject in high-risk group. In the third week, it 
occurred 4 times out of the monitoring 
schedule. It occurred at 14.00-15.00 WIB, 
which were on 2 subjects in high-risk group 
and one subject of very high-risk group. 
  There is no subject who needs special 
medical treatment though hospital care 
related to hypoglycemic complication or 
hyperglycemia. 
Results of Blood Glucose Monitoring of the 
First, Second, and Third Week 
  Description of changes of blood 
glucose mean in each risk group is in Figure 2. 
The most noticeable blood glucose fluctuation 
in the first week of Ramadan fasting was in 
very high-risk group, especially in the 2nd and 
3rd day of fasting. 
 
 
Figure 2. Mean of Blood Glucose in the 1st Week of 
Ramadan Fasting Based on Risk Category 
 
Blood glucose level before iftar in the 
2nd week of 3 risk groups was relatively 
balanced. It showed in Figure 3 and 4. Blood 
Glucose 2-hours after Iftar in the 2nd week 
seemed higher than the first testing for each 
risk group. In second and third testing, the 
blood glucose level of 2-hours after meal 
seemed dropping and the lowest seemed at 
the third testing for mild/moderate and high-
















Figure 3. Mean of Blood Glucose Before Iftar in the 2nd 
Week of Ramadan Fasting of each Risk Category  
 
 
*BG, Blood Glucose  
Figure 4. Mean of Blood Glucose 2-hours after meal in the 
2nd Week of Ramadan Fasting of each Risk Category  
Explanation of mean of blood glucose 
before iftar in the third week is in Figure 5 and 
6. It shows glucose blood level in 3 groups are 
relatively balanced. Mean of blood glucose 2 
hours after iftar in the 3rd week of Ramadan 
fasting is lower than 2nd week. 
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*BG, Blood Glucose  
Figure 5. Mean of Blood Glucose Before Iftar in the 3rd 
Week of Ramadan Fasting of each Risk Category  
 
*BG, Blood Glucose  
Figure 6. Mean of Blood Glucose 2-hours after Iftar in the 
3rd Week of Ramadan Fasting of each Risk Category  
Others Acute Complications 
 Apart from hypoglycemia and 
hyperglycemia, there was one subject who has 
complication, such as acute coronary 
syndrome. It was a subject of very high-risk 
group. Subject who got Unstable Angina 
Pectoris in 3rd week of Ramadan fasting and 
need a hospital care. Diabetic ketoacidosis 
(DKA) was not found in subject who undergo 
Ramadan fasting. 
Correlation between Risk Stratification and 
Acute Complication 
We used comparative analysis 
(categorical) which is Chi-Square to determine 
the relationship between the risk stratification 
of Ramadan fasting on the incidence of acute 
complications in DM patients who did 
Ramadan fasting, a categorical comparative 
analysis is used, namely Chi-Square. From the 
analysis, it is known that the Chi-Square 
assumptions have not been fulfilled so that the 
test is replaced by using Kruskal Wallis with a 
p value = 0.009. The p value <0.05 indicates 
that there is a correlation between the risk 
stratification of Ramadan fasting and the 
incidence of acute complications in DM 
patients who observe Ramadan fasting. This is 
explained in Table 3. 
Table 3. The Correlation between Risk Stratification and 
















































  0 







a= hyperglycemia and hypoglycemia 
Based on these results, analysis was 
performed with the Mann Whitney test to find 
out which risk stratification has a different 
complication result, which is described in 
Table 3. From the results of the Mann Whitney 
test, it is known that there is a significant 
difference in the incidence of acute 
complications between the mild/moderate 
and very high-risk stratification groups (p = 
0.003). Comparative tests between high and 
very high-risk groups also had a significant 
difference in the incidence of acute 
complications (p= 0.038). 
To determine the relationship 
between the risk stratification of Ramadan 
fasting on the total incidence of hypoglycemia 
and hyperglycemia in DM patients during 
Ramadan fasting, correlation analysis 
Spearman's (categorical vs numeric) was 
used. 
From the results of the Spearman 
correlation analysis obtained p-value in DM 
risk stratification correlation with a total 
incidence of hyperglycemia complication is 
0.040. The p- value <0.05 indicates that there 
is a correlation between the risk stratification 
of DM with the number of complications of 
hyperglycemia. In relation to the risk 
stratification of DM with the number of 
complications of hypoglycemia, the p-value is 
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0.031. The p-value <0.05 indicates that there 
is a correlation between the risk stratification 
of DM and the number of complications of 
hypoglycemia. 
To determine the relative risk of acute 
complications of fasting based on risk 
stratification, the mild/moderate risk group 
was used as a comparison. The results are 
described in Table 4. Patients in the very high-
risk group had 2.5 times chance of developing 
complications from experiencing acute 
complications compared to patients in the 
moderate risk group. 
Table 4. Relative Risks of Complications of Acute Fasting 






P-value RR (IK 95%) 





1 (16.7) 5 (83.3) 0.046 2.53 (0.800–8.058) 




11 (84.6) 2 (15.4)  Standard of 
comparison 
 
Correlation of Risk Stratification and Types of 
Antihyperglycemic Drugs 
 We used Kruskal Wallis analysis to 
know correlation between types of therapy of 
acute complication in DM patient who fast in 
Ramadan because Chi-square provision was 
not fulfilled. It was explained in Table 5. 
Table 5. Correlation between Types of 























































*OAD, oral antidiabetic 
 The most acute complication was 
found in OAD combination with insulin 
therapy group (2/4) compared to OAD 
combination and insulin therapy without 
combination, with p-value >0.05 showed that 
there is no correlation between types of 
therapy on acute complication in DM patient 
who did Ramadan fasting. 
D I S C U S S I O N 
Mean of fasting day in this study is 18 
days. It is in line with EPIDIAR result which is 
the largest research discussed about 
Ramadan. The result was a total of 79% of 
type-2 DM patient and 43% of type-1 DM 
patient were fasting in at least 15 days during 
Ramadan. 
In this study, acute complication was 
not happened to 23 subjects during Ramadan 
fasting. The prevalence of hypoglycemia and 
hyperglycemia were 13.51% (5/37) and 
10.8% (4/37), and there are 10.8% subjects 
(4/37) who experienced acute complication 
like hypoglycemia and hyperglycemia 
alternatively during fasting day in Ramadan. A 
total of 14 subjects who experienced acute 
complication, there are 57 incidence of 
complication report that 22% of it, is 
hypoglycemia and 57.89% is hyperglycemia. 
Ahmedani, et al.’s study showed the 
prevalence of hypoglycemia (21.7%) was a 
slightly higher than hyperglycemia (19.8%) in 
327 DM patients who were fasting in Pakistan 
and there is no difference between prevalence 
of hypoglycemia and hyperglycemia in type-1 
DM patient and type-2 DM patient during 
Ramadan.[11] 
There is none hypoglycemia found in 
this study need to be hospitalized. 
Hypoglycemia was found to occur most 
frequently between 13.00 until before Iftar. 
Some subjects reported the hypoglycemia to 
the research team and cancelled their fasting 
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when hypoglycemia occurred, but there were 
also subjects who did not report this finding 
and continued fasting despite knowing that 
they got hypoglycemia. 
Hyperglycemia was occurred at 
various times but most commonly happened 
after Iftar, with the highest blood glucose level 
recorded being 540 mg/dL in patients after 
Iftar. However, there were no subjects with 
severe hyperglycemia requiring further 
hospitalization. Factors that contribute to the 
increased risk of hyperglycemia during 
Ramadan include the food consumed during 
iftar, which is heavy food with high 
carbohydrate content and cooked by frying, 
and consumption of drinks and sweet 
snacks.[14] The reduced physical activity during 
the fasting month of Ramadan also contributes 
to the incidence of hyperglycemia.[15] 
However, in this study, it cannot be known 
about the measurable changes in the physical 
activity of the subjects, as well as changes in 
dietary patterns during Ramadan compared to 
pre-Ramadan so that the correlation between 
the two with the incidence of hypoglycemia 
and hyperglycemia cannot be concluded. 
Although there is an acute 
complication of hyperglycemia, this study did 
not find subjects who had DKA. DKA itself is 
often mentioned in expert recommendations 
as one of the most likely acute complications 
during Ramadan fasting. The risk of DKA is 
considered to increase during Ramadan 
because fasting itself will result in 
hypoinsulinemia and hyperglucagonemia, as 
well as the formation of ketone bodies which 
will then cause DKA.[16] However, it becomes a 
speculation among experts, that there are no 
studies showing that the incidence of DKA 
does increase during Ramadan. One study 
showed that only 2.5% of DM patients in Libya 
studied had DKA during Ramadan fasting.[10]  
Another study showed no increase in 
incidence and mortality due to DKA during 
Ramadan which indicates that fasting in 
Ramadan is a significant risk factor for DKA.[16] 
A critical reappraisal by Beshyah, et al. added 
although DKA can occur during the fasting 
month of Ramadan, this may be due to 
precipitation from other factors not related to 
fasting itself, and there is no sufficiently strong 
evidence that the risk of DKA will increase 
during Ramadan fasting. Further study with a 
larger sample is needed to prove this.[17] 
Acute complications were recorded 
most frequently in the 1st week of fasting in 
Ramadan, namely 50.88% (29/57), of which 
62% (18/29) were hyperglycemia. This may 
be because the patient is still adapting to 
changes in meal times, and the increased 
consumption of high-carbohydrate foods at 
iftar and dawn, accompanied by changes in 
physical activity. These findings suggest that 
monitoring of blood glucose and the patient's 
general condition should be done more 
intensively during the first week of fasting in 
Ramadan. 
There is a statistically significant 
correlation between risk stratification and the 
incidence of acute complications. Based on 
these results, it can be concluded that the DM 
patients’ classification on the risk 
stratification of Ramadan fasting 
complications is an important thing to do and 
should be part of the pre-Ramadan education 
for DM patients who want to fast in Ramadan.  
By classifying based on risk 
complication initially, patients can get medical 
advice that it would be more safety for them 
not to fast if there is a high-risk of 
complications during fasting, and if they still 
decide to fast, the patient already knows the 
types of complications risk and how big the 
chances of complications are that can happen 
to them, and able to take steps to prevent 
complications, and tighter supervision during 
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fasting by themselves, the people around them 
and the doctors who treat them.[17] 
There are many factors that can affect 
the incidence of acute complications during 
Ramadan fasting, one of which is type of 
antihyperglycemia drug. To determine the 
correlation between the type of therapy and 
the incidence of acute complications in DM 
patients undergoing Ramadan fasting, Kruskal 
Wallis categorical comparative analysis was 
used with a value of p = 0.731. The p value> 
0.05 indicates there is no correlation between 
the type of therapy and the incidence of acute 
complications in DM patients who observe 
Ramadan fasting. 
In this study, the observed 
pharmacological therapy factor was the type 
of antihyperglycemic drug, without 
considering whether the patient had adjusted 
the therapeutic regimen according to previous 
pre-Ramadan counseling, and the factors for 
changing the time to take antihyperglycemia 
drug during Ramadan fasting. However, a 
study by Ahmedani, et al showed that changes 
in the timing of taking antihyperglycemia had 
no significant effect on the incidence of 
hypoglycemia or hyperglycemia during 
Ramadan.[11] This finding is not in line with the 
EPIDIAR study which showed a significant 
relationship between the incidence of severe 
hypoglycemia with changes in insulin and OAD 
during fasting Ramadan and changes in 
physical activity during fasting Ramadan. [18] 
This study is a pilot study which 
determine glucose control in DM patients who 
are fasting in Malang. Further research is 
needed with maximum research handling to 
determine the factors that influence the 
incidence of acute complications such as diet, 
pre-Ramadan education, physical activity and 
sleep patterns, and to find out whether there 
are other factors related to therapy that affect 
the incidence of acute complications, such as 
changes in therapy regimens and changes in 
dosage, as well as changes in the timing of drug 
consumption. 
C O N C L U S I O N 
There is a correlation between risk 
stratification and the incidence of acute 
complications in DM patients who undergo 
Ramadan fasting. There is no correlation 
between the type of antihyperglycemic drugs 
and the incidence of acute complications in DM 
patients who undergo Ramadan fasting. 
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